Taking Wegovy Every 6 Days: What the Evidence Actually Says

Why the seven-day gap is baked into how semaglutide works

Semaglutide has a long half-life (roughly one week) which is precisely why Wegovy was designed as a weekly injection. The dose is calculated on the assumption that your body clears a predictable proportion between injections. Compress the gap to six days and you are stacking a new dose on top of slightly higher residual levels than the schedule anticipates. Over time, that difference accumulates.

This matters more than it might seem. The side-effect profile of Wegovy (nausea, vomiting, diarrhoea, constipation) is heavily tied to peak plasma concentrations. The NHS medicines guidance on semaglutide notes that these effects are particularly common early in treatment and after dose increases, both of which involve the body adapting to higher levels of the medicine. A consistently shortened interval mimics that pattern artificially.

The full Wegovy overview explains the titration schedule in detail, but the short version is that the licensed path from 0.25 mg to 2.4 mg (or up to the newer 7.2 mg maintenance dose) was tested on weekly dosing. Deviating from that schedule means you are operating outside the conditions of the clinical trials that established both the safety and the effectiveness data.

What actually happens if you inject a day early?

A single six-day interval (because a particular day of the week is inconvenient, or you forgot and caught yourself early) is unlikely to cause serious harm for most people. Prescribers acknowledge that real life is imperfect. The Mounjaro and Wegovy SmPCs (the full prescribing documents held on the Electronic Medicines Compendium) address the missed-dose scenario: if your next scheduled day is more than two days away, take the missed dose; if it is within two days, skip it and resume on the usual day. That advice runs in one direction only, it does not suggest taking doses early.

Habitually taking Wegovy every six days is a different matter. You are, in effect, choosing a dosing schedule that was never tested. A question our prescribers hear regularly is whether slightly more frequent dosing might accelerate results. The honest answer is: the trial data does not support that conclusion, and the risk of compounding side effects is real. Some people also ask about even shorter intervals, the reasoning above applies with greater force the further you shorten the gap.

If your current schedule genuinely is not working for practical reasons, the right conversation is with your prescriber, who can look at your whole picture rather than just the calendar.

When the interval question is really about something else

People searching this question are often trying to solve a different problem: results feel slow, a dose increase has been delayed, or life got in the way and they are trying to catch up. Those are all legitimate frustrations. The answer to slow progress on Wegovy is rarely a shorter injection interval, it is more likely a combination of factors including where you are in the titration schedule, diet, activity and individual biology.

For context on who this medicine is licensed for and what realistic weight-loss expectations look like, the BMI eligibility guidance for Wegovy is a useful starting point. It is also worth reading about what else you are taking, some supplements and medicines interact with semaglutide in ways that affect how well the treatment works, and a prescriber can review that properly.

If you are weighing up whether Wegovy is the right treatment at all, or want to understand the broader landscape of licensed weight-loss options in the UK, that context is worth having before changing anything about your current dosing.

The right next step if your schedule is not working

Wegovy is a prescription-only medicine. That status exists because decisions about dosing, timing and any adjustments to the schedule require clinical input, they are not self-service choices. If you are considering changing your injection day, have missed doses and are unsure how to proceed, or are questioning whether your current dose is right for you, your prescriber is the correct port of call.

At nume, a real clinician reviews every consultation and every repeat order, not software, not a questionnaire scored by an algorithm. If you are not yet a patient and want that kind of oversight from the start, you can start a free consultation and a GPhC-registered prescriber will review your case the same day. Treatment, once approved, arrives by tracked DPD delivery the next working day in plain, unbranded packaging, so the practical side is straightforward. The clinical side is where the care actually lives.

For those thinking about whether weekly dosing is genuinely necessary, the question of fortnightly injections is covered separately, as is extending the interval to ten days. The answer in each case draws on the same principle: the licensed schedule exists for reasons grounded in pharmacology, and changes to it belong in a clinical conversation. You can also review our frequently asked questions for further guidance on managing your treatment.